Show simple item record

dc.contributor.authorAkarsu, S.
dc.contributor.authorDemir, S.
dc.contributor.authorGode, F.
dc.contributor.authorIşık, A.Z.
dc.date.accessioned2019-06-30T20:29:35Z
dc.date.available2019-06-30T20:29:35Z
dc.date.issued2017
dc.identifier.issn1307699X
dc.identifier.urihttp://eds.b.ebscohost.com/eds/pdfviewer/pdfviewer?vid=0&sid=0a537034-31f7-4014-8e6c-d57018a32a8e%40pdc-v-sessmgr01
dc.identifier.urihttp://hdl.handle.net/11727/3763
dc.description.abstractObjective: The aim of this study was to compare the effect of corifollitropin alfa (CFA) and recombinant follicle-stimulating hormone (rFSH) in poor-responder patients undergoing antagonist cycles. Materials and Methods: The study was a retrospective analysis of the treatment results of 214 poor responder patients who had been admitted to the In Vitro Fertilization Unit of İzmir Medical Park Hospital between November 2014 and November 2016. Intracytoplasmic sperm injections were performed in 38 patients (group 1) with CFA, and the remaining 176 (group 2) with rFSH for controlled ovarian hyperstimulation. Results: The age, body mass index, anti-müllerian hormone level, duration of infertility, duration of induction and antral follicle number were similar in the two groups. There was no difference in the total aspirated oocyte counts, mature oocyte ratio, fertilization rate, implantation rate, and clinical pregnancy rates between the two groups. The implantation rate was 9/38 (23.6%) in group 1 and 42/176 (23.8%) in group 2, whereas the clinical pregnancy rates were 16.3% and 17.2%, respectively. Conclusion: No difference was found in terms of oocyte count, fertilization rate, implantation rate, and clinical pregnancy rates of CFA or rFSH use in the antagonist cycles in poor-responder patients. © 2017 by Turkish Society of Obstetrics and Gynecology.en_US
dc.language.isoengen_US
dc.relation.isversionof10.4274/tjod.08634en_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectCorifollitropin alfaen_US
dc.subjectDiminished ovarian reserveen_US
dc.subjectGonadotropin-releasing hormone antagonisten_US
dc.subjectIn vitro fertilizationen_US
dc.subjectPoor responderen_US
dc.titleComparison of corifollitropin alfa and daily recombinant follicle-stimulating hormone in poor responder patients undergoing in vitro fertilization cyclesen_US
dc.typearticleen_US
dc.relation.journalTurk Jinekoloji ve Obstetrik Dernegi Dergisien_US
dc.identifier.volume14en_US
dc.identifier.issue4en_US
dc.identifier.startpage199en_US
dc.identifier.endpage202en_US
dc.identifier.scopus2017-2


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record